Gwyneth Davies

4.3k total citations · 2 hit papers
59 papers, 1.3k citations indexed

About

Gwyneth Davies is a scholar working on Pulmonary and Respiratory Medicine, General Health Professions and Physiology. According to data from OpenAlex, Gwyneth Davies has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 12 papers in General Health Professions and 11 papers in Physiology. Recurrent topics in Gwyneth Davies's work include Cystic Fibrosis Research Advances (31 papers), Neonatal Respiratory Health Research (16 papers) and Tracheal and airway disorders (10 papers). Gwyneth Davies is often cited by papers focused on Cystic Fibrosis Research Advances (31 papers), Neonatal Respiratory Health Research (16 papers) and Tracheal and airway disorders (10 papers). Gwyneth Davies collaborates with scholars based in United Kingdom, Canada and United States. Gwyneth Davies's co-authors include James Y. Paton, J.J. Reilly, Jane Hislop, V. Penpraze, Suzanne Grant, John J. Reilly, Jane C. Davies, Alan R Smyth, Philip Tucker and Anna Dahlgren and has published in prestigious journals such as Nature Communications, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Gwyneth Davies

53 papers receiving 1.3k citations

Hit Papers

Future therapies for cystic fibrosis 2023 2026 2024 2025 2023 2025 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Future therapies for cystic fibrosis
    2023 71 citations Lucy Allen, S.B. Carr et al. Nature Communications profile →
  2. Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
    2025 22 citations Jordana E. Hoppe, Ajay S. Kasi et al. The Lancet Respiratory Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gwyneth Davies United Kingdom 17 501 451 417 264 204 59 1.3k
Adrienne Stolfi United States 20 204 0.4× 648 1.4× 192 0.5× 86 0.3× 167 0.8× 99 2.0k
Francesca Orsini Australia 19 449 0.9× 144 0.3× 233 0.6× 42 0.2× 120 0.6× 55 1.6k
David J. Tybor United States 16 54 0.1× 716 1.6× 257 0.6× 247 0.9× 229 1.1× 49 1.4k
Martha Elwenspoek United Kingdom 14 56 0.1× 658 1.5× 205 0.5× 105 0.4× 374 1.8× 33 1.2k
Rakesh Patel United Kingdom 19 91 0.2× 475 1.1× 141 0.3× 55 0.2× 150 0.7× 95 1.2k
Soyang Kwon United States 23 42 0.1× 753 1.7× 509 1.2× 362 1.4× 275 1.3× 109 1.6k
Susan Jacob United States 19 156 0.3× 139 0.3× 49 0.1× 127 0.5× 189 0.9× 80 1.3k
Jennifer L. P. Protudjer Canada 24 112 0.2× 389 0.9× 377 0.9× 18 0.1× 140 0.7× 134 1.8k
Callie L. Brown United States 17 165 0.3× 540 1.2× 268 0.6× 19 0.1× 314 1.5× 61 1.2k
Richard Stanwick Canada 17 109 0.2× 331 0.7× 114 0.3× 54 0.2× 146 0.7× 40 1.1k

Countries citing papers authored by Gwyneth Davies

Since Specialization
Citations

This map shows the geographic impact of Gwyneth Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gwyneth Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gwyneth Davies more than expected).

Fields of papers citing papers by Gwyneth Davies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gwyneth Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gwyneth Davies. The network helps show where Gwyneth Davies may publish in the future.

Co-authorship network of co-authors of Gwyneth Davies

This figure shows the co-authorship network connecting the top 25 collaborators of Gwyneth Davies. A scholar is included among the top collaborators of Gwyneth Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gwyneth Davies. Gwyneth Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoppe, Jordana E., Ajay S. Kasi, Jessica E. Pittman, et al.. (2025). Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial. The Lancet Respiratory Medicine. 13(3). 244–255. 22 indexed citations breakdown →
2.
Lee, Tim, Daan Caudri, Pierluigi Ciet, et al.. (2025). Pulmonary endpoints in clinical trials for children with cystic fibrosis under two years of age. Journal of Cystic Fibrosis. 24(4). 669–683. 1 indexed citations
3.
Tibble, Holly, Andrew Bush, Steve Cunningham, et al.. (2025). Using routine primary care data in research: (in)efficient case studies and perspectives from the Asthma UK Centre for Applied Research. BMJ Health & Care Informatics. 32(1). e101134–e101134.
4.
5.
Turner, David, Gwyneth Davies, Janice Abbott, et al.. (2024). Measurement of treatment burden in cystic fibrosis: A systematic review. Journal of Cystic Fibrosis. 24(3). 434–445.
6.
7.
Arigliani, Michele, et al.. (2024). Looking beyond LCI: Multiple breath washout phase III slope derived indices and their application in chronic respiratory disease in children. Pediatric Pulmonology. 59(12). 3085–3094. 3 indexed citations
8.
9.
Filipow, Nicole, et al.. (2023). Real-world effectiveness of airway clearance techniques in children with cystic fibrosis. European Respiratory Journal. 62(3). 2300522–2300522. 4 indexed citations
10.
Allen, Lucy, S.B. Carr, Gwyneth Davies, et al.. (2023). Future therapies for cystic fibrosis. Nature Communications. 14(1). 693–693. 71 indexed citations breakdown →
11.
MacDougall, Amy, Deborah Jarvis, Ruth H. Keogh, et al.. (2022). Trajectories of early growth and subsequent lung function in cystic fibrosis: An observational study using UK and Canadian registry data. Journal of Cystic Fibrosis. 22(3). 388–394. 4 indexed citations
12.
Aurora, P., Sooky Lum, Gwyneth Davies, et al.. (2022). Early Pseudomonas aeruginosa predicts poorer pulmonary function in preschool children with cystic fibrosis. Journal of Cystic Fibrosis. 21(6). 988–995. 7 indexed citations
13.
Filipow, Nicole, Gwyneth Davies, Eleanor Main, et al.. (2021). Unsupervised phenotypic clustering for determining clinical status in children with cystic fibrosis. European Respiratory Journal. 58(2). 2002881–2002881. 8 indexed citations
14.
Davies, Gwyneth, L. Thia, Janet Stocks, et al.. (2020). Minimal change in structural, functional and inflammatory markers of lung disease in newborn screened infants with cystic fibrosis at one year. Journal of Cystic Fibrosis. 19(6). 896–901. 16 indexed citations
15.
Davies, Gwyneth, et al.. (2020). Monitoring early stage lung disease in cystic fibrosis. Current Opinion in Pulmonary Medicine. 26(6). 671–678. 15 indexed citations
16.
Rowbotham, Nicola J., Gwyneth Davies, Zoe Elliott, et al.. (2019). ePS3.04 Can exercise replace airway clearance? A survey of lay and professional views. Journal of Cystic Fibrosis. 18. S45–S45. 1 indexed citations
17.
Davies, Gwyneth, et al.. (2015). IMPROVED LUNG FUNCTION IN PRESCHOOL CHILDREN WITH CF OVER THE LAST DECADE. UCL Discovery (University College London). 1 indexed citations
18.
Alton, Eric W.F.W., Alan Boyd, David J. Porteous, et al.. (2015). A Phase I/IIa Safety and Efficacy Study of Nebulized Liposome-mediated Gene Therapy for Cystic Fibrosis Supports a Multidose Trial. American Journal of Respiratory and Critical Care Medicine. 192(11). 1389–1392. 40 indexed citations
19.
Irving, Samantha, Gwyneth Davies, Jackie Donovan, et al.. (2013). Lung Clearance Index and High-Resolution Computed Tomography Scores in Primary Ciliary Dyskinesia. American Journal of Respiratory and Critical Care Medicine. 188(5). 545–549. 60 indexed citations
20.
Brown, Menna, Philip Tucker, Frances Rapport, et al.. (2010). The impact of shift patterns on junior doctors' perceptions of fatigue, training, work/life balance and the role of social support. BMJ Quality & Safety. 19(6). e36–e36. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adrienne Stolfi Breakdown of academic impact, for papers by Francesca Orsini Breakdown of academic impact, for papers by David J. Tybor Breakdown of academic impact, for papers by Martha Elwenspoek Breakdown of academic impact, for papers by Rakesh Patel Breakdown of academic impact, for papers by Soyang Kwon Breakdown of academic impact, for papers by Susan Jacob Breakdown of academic impact, for papers by Jennifer L. P. Protudjer Breakdown of academic impact, for papers by Callie L. Brown Breakdown of academic impact, for papers by Richard Stanwick
Rankless by CCL
2026